1. Ilyinov A.N., Ryazanov I.A., Osipov A.N. Acid erythrograms of mice poisoned with Zn, Cd and Pb. Toxicological Bulletin.1997; 14: 10-14.
2. Wang Bo, Yanli Du. Cadmium and Its Neurotoxic Effects. Oxid Med Cell Longev. 2013; 2013: 898034. [
DOI:10.1155/2013/898034]
3. Charkiewicz A.E., Omeljaniuk W.J., Nowak K.K., Garley M., and Niklinski J. Cadmium Toxicity and Health Effects-A Brief Summary. Molecules. 2023; 28(18): 6620. [
DOI:10.3390/molecules28186620]
4. Blainey JD, Adams RG, Brewer DB, Harvey TC. Cadmium-induced osteomalacia. Br J Ind Med. 1980; 37(3): 278-84. [
DOI:10.1136/oem.37.3.278]
5. Fiévez L., Kirschvink N., Zhang W., Lagente V., Lekeux P., Bureau F., Gustin P. Effects of betamethasone on inflammation and emphysema induced by cadmium nebulisation in rats. Pulmonary, Gastrointestinal and Urogenital Pharmacology. 2009; 606(1-3): 210-214. [
DOI:10.1016/j.ejphar.2009.01.020]
6. Gallagher CM, Meliker JR. Blood and urine cadmium, blood pressure, and hypertension: a systematic review and meta-analysis. Environ Health Perspect.2010;118 (12):1676-84. [
DOI:10.1289/ehp.1002077]
7. Thévenod F. Nephrotoxicity and the Proximal Tubule: Insights from Cadmium Subject Area. Nephron Physiology.2003; 93(4): 87-93.. [
DOI:10.1159/000070241]
8. Helmestam M., Stavreus-Evers A., Olovsson M. Cadmium chloride alters mRNA levels of angiogenesis related genes in primary human endometrial endothelial cells grown in vitro. Reprod.Toxicol. 2010; 30(3): 370-376.doi: 10.1016/j.reprotox.2010.05.003. [
DOI:10.1016/j.reprotox.2010.05.003]
9. Waalkes MP, Rehm S. Cadmium and prostate cancer. J Toxicol Environ Health. 1994 Nov; 43(3):251-69. [
DOI:10.1080/15287399409531920]
10. Prozialek WC, Edwards JR, Woods JM. The vascular endothelium as a target of cadmium toxicity. Life Sci. 2006; 79: 1493-1506. [
DOI:10.1016/j.lfs.2006.05.007]
11. Wang X. et al. Low doze cadmium upregulates the expression of von Willebrand factor in endothelial cells. Toxicol. Lett. 2018; 290: 46-54. [
DOI:10.1016/j.toxlet.2018.03.020]
12. Kokame K, Sakata T, Kokiwo Y, Miyata T. von Willebrand factor-to. ADAMTS13 ratio increases with age in a Japanese population. J.Thromb. Haemost. 2011; 9: 1426-1428. [
DOI:10.1111/j.1538-7836.2011.04333.x]
13. Hasimoto Y, et al. Relationship between age and plasma t-PA, PA-inhibitor, and PA activity. Thromb. Res. 1987; 46: 625-633. [
DOI:10.1016/0049-3848(87)90264-7]
14. Samoilov M.V., Naumov A.G. Morphofunctional characteristics of erythrocytes as a criterion of the severity of endogenous intoxication. Russian medical journal. 2000; 1: 31-33.
15. Suwalsky M. , Villena F., Norris B., Cuevas F., Sotomayor C․ Cadmium-induced changes in the membrane of human erythrocytes and molecular models․ J Inorg Biochem, 2004; 98(6): 1061-6. DOI: [
DOI:10.1016/j.jinorgbio.2004.02.027]
16. Verbost P.M., Flik G., Pang P.K., Lock R.A., Wendelaar Bonga S.E. Cadmium inhibition of the erythrocyte Ca2+ pump. Jour. Biol. Chem. 1989; 264: 5613. [
DOI:10.1016/S0021-9258(18)83591-8]
17. Paronyan, Z. Kh., Khachatryan R. S., Stepanyan A. A., Grigoryan L. S., Arakelyan L. N. Changes in glucose levels and some blood coagulation parameters in rats with experimental alloxan-induced diabetes under the influence of a new amino acid complex. Medical Science of Armenia. NAS RA; 2021: 61(3): 64-72.
18. Paronyan Z.Kh.,Araqelyan L.N., Grigoryan L.S., Khachatryan R.S., Galstyan A.Z., Stepanyan A.A. The influence of an antidiabetic amino acid complex on some parameters of plasma hemostasis. Medical Science of Armenia. 2023; 63(3): 64-71. doi:10.54503/0514-7484-2023-63.3-64. [
DOI:10.54503/0514-7484-2023-63.3-64]
19. Edigarova L.V., Akopyan V.G. Antiplatelet activity of the vascular wall and the possibility of its correction with GABAergic agents in conditions of hypokinesia. Experimental and clinical pharmacology, 2000. 5, p. 41 - 43.
20. Fischer A, Jacobson KA, Rose J and Zeller R: Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc pdb.prot4986, 2008. [
DOI:10.1101/pdb.prot4986]
21. Redginal H: Giemsa preparation for staining blood films. Science 86: 548, 1937. [
DOI:10.1126/science.86.2241.548]
22. Zubairov D.M. Coagulation disorders due to vitamin K deficiency and indirect anticoagulants. KAZAN MEDICAL JOURNAL. 1995; 76(4):344-346. doi:
https://doi.org/10.17816/kazmj105001 [
DOI:10.17816/kazmj105001.]
23. Beth H.Shar MD, Christofer D. Hillyer MD. Cryoprecipitate and Fibrinogen Concentrates Transfusion Medicine and Hemostasis (Second Edition). 2013.
24. Barbier O, Iacqullet G.,Taic M. et al. Acute study of interaction between cadmium, calcium and zinc transport along the rat nephron in vivo, Am. I.Physiol. Renal. Physiol. 2004; 287:1067-1075. [
DOI:10.1152/ajprenal.00120.2004]
25. Kranias E.G., Bers D.M. Calcium and cardiomyopathies, Subcell. Biochem. 2007; 45: 523-537. [
DOI:10.1007/978-1-4020-6191-2_20]
26. Chandrasekar Palaniswamy MD, Arunabh Sekhri MD, Wilbert S. Aronow MD, Ankur Kalra MD, Stephen J. Peterson MD, MACP. Association of Warfarin Use With Valvular and Vascular Calcification: A Review. Clinical Cardiology. 2011;34(2): 74-81. [
DOI:10.1002/clc.20865]
27. Shea M.K., Cushman, S.L. Booth, G.L. Burke and HCSB Krichevsky, Vitamin K status and vascular calcification: evidence from observational and clinical studies. Advances in Nutrition. 2012; 3(2): 158-165. [
DOI:10.3945/an.111.001644]
28. Krüger T., Westenfeld R., Schurgers L., Vincent M. Brandenburg. Coagulation Meets Calcification: The Vitamin K System. The International journal of artificial organs. 2009; 32(2): 67-74. [
DOI:10.1177/039139880903200202]
29. Prorialeck WC, Edwards JR, Woods JM. The vascular endothelium as a target of cadmium toxicity. Life Sci. 2006; 79: 1493-1506. [
DOI:10.1016/j.lfs.2006.05.007]
30. Wang X, et al. Low doze cadmium upregulates the expression if von Willebrand factor in endothelial cells. Toxicol. Lett. 2018; 290: 46-54. [
DOI:10.1016/j.toxlet.2018.03.020]
31. Albanes S. et al. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms. J. Thromb. Haemost. 2016; 14: 953- 963. [
DOI:10.1111/jth.13294]